Allogeneic hematopoietic cell transplantation (alloHCT) using tremtelectogene empogeditemcel (trem-cel), a CRISPR–Cas9–edited ...

ChristianaCare’s Gene Editing Institute has launched DECODR, Inc., a new for‑profit company created to expand access to one of the world’s leading software tools to evaluate the effectiveness of ...

Tuberculosis (TB) remains one of the leading causes of mortality from a single infectious agent worldwide and continues to pose a major public health ...

Experienced Life Sciences Patent Attorney Strengthens Firm’s IP Capabilities ATLANTA—(May 12, 2026)—FisherBroyles, LLP, the world’s first and one of the largest distributed law firms, is pleased to ...

UC Davis researchers engineered wheat that encourages soil bacteria to convert atmospheric nitrogen into plant-usable fertilizer. By boosting a natural compound in the plant, the wheat triggers ...

Cathie Wood's ARKK ETF features Tesla, AMD, Coinbase, and CRISPR Therapeutics as top holdings. Discover the fund's focus on ...

DNA synthesis technologies, supported by automated synthesizers, high-throughput platforms, oligonucleotide production ...

Live-cell breakthrough: Munich scientists created a method to repeatedly read genetic activity from living cells, enabling long-term study without cell destruction. CRISPR reimagined: Hong Kong ...

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...

Short QT syndrome is a genetic disease that leads to sudden cardiac death at a young age. Mutations in the SLC4A3 gene, which ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Bacteria fend off invading viruses with molecular scissors that slice up viral DNA—a system called CRISPR that's become ...